C. Salvador-Coloma

Incidence, predictors and prognostic significance of thromboembolic disease in patients with advanced ALK-rearranged non-small cell lung cancer

L. Paz-Ares, V. Calvo, C. Font, 2018, European Respiratory Journal.

Immunosuppressive profiles in liquid biopsy at diagnosis predict response to neoadjuvant chemotherapy in triple-negative breast cancer.

D. Hervás, G. Quintás, A. Santaballa, 2020, European journal of cancer.

Adherence and adverse events of intraperitoneal chemotherapy in optimally debulked ovarian cancer patients: Real-life study

J. Poveda-Andrés, C. Salvador-Coloma, O. Ballesta-López, 2020, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Multidisciplinary Care of Laryngeal Cancer.

E. Cohen, C. Salvador-Coloma, E. Cohen, 2016, Journal of Oncology Practice.

Identification Of Actionable Genetic Targets In Primary Cardiac Sarcomas

E. Mayordomo, R. Diaz-Beveridge, J. Font de Mora, 2019, OncoTargets and therapy.

Early radiological response as predictor of overall survival in non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor mutations.

J. Sandoval, A. Lahoz, D. Lorente, 2018, Journal of thoracic disease.

Long term survival after brain metastases from malignant melanoma

J. Aparicio, J. Montalar, C. Salvador-Coloma, 2016 .

Predictive and prognostic clinical and pathological factors of nivolumab efficacy in non-small-cell lung cancer patients

X. Mielgo-Rubio, P. Martín-Martorell, C. Salvador-Coloma, 2018, Clinical and Translational Oncology.

Beyond the first line of HER2+ metastatic breast cancer

C. Salvador-Coloma, 2023, Revisiones en Cáncer.

Intestinal pseudo-obstruction: An important diagnostic challenge

Ó. Gómez, C. Salvador-Coloma, Ó. J. Vidal, 2015 .